Cargando…

Technical Solutions to Ensure Safe Yttrium-90 Radioembolization in Patients With Initial Extrahepatic Deposition of (99m)Technetium–Albumin Macroaggregates

PURPOSE: To evaluate the incidence of extrahepatic deposition of technetium-99m–labeled albumin macroaggregates ((99m)Tc-MAA) after pretreatment angiography, before yttrium-90 radioembolizaton ((90)Y-RE), and to report on technical solutions that can be used to ensure safe delivery of (90)Y-microsph...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barentsz, M. W., Vente, M. A. D., Lam, M. G. E. H., Smits, M. L. J., Nijsen, J. F. W., Seinstra, B. A., Rosenbaum, C. E. N. M., Verkooijen, H. M., Zonnenberg, B. A., Van den Bosch, M. A. A. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2010
Materias:	Technical Note
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170462/ https://www.ncbi.nlm.nih.gov/pubmed/21191588 http://dx.doi.org/10.1007/s00270-010-0088-4

Ejemplares similares

Personalized predictive lung dosimetry by technetium-99m macroaggregated albumin SPECT/CT for yttrium-90 radioembolization
por: Kao, Yung Hsiang, et al.
Publicado: (2014)

Artifactual Hot Spots on Technetium-99m Macroaggregated Albumin Perfusion Lung Scan
por: Sebbar, Chaimae, et al.
Publicado: (2023)

Fast technetium‐99m liver SPECT for evaluation of the pretreatment procedure for radioembolization dosimetry
por: van der Velden, Sandra, et al.
Publicado: (2018)

Yttrium-90 radioembolization for colorectal cancer liver metastases: a prospective cohort study on circulating angiogenic factors and treatment response
por: Rosenbaum, C. E. N. M., et al.
Publicado: (2016)

Transportal Technetium-99m Labeled Macroaggregated Albumin Scintigraphy to Quantify Occult Intrahepatic Microvascular Portosystemic Shunting
por: De la Garza-Ramos, Cynthia, et al.
Publicado: (2021)

The superior predictive value of (166)Ho-scout compared with (99m)Tc-macroaggregated albumin prior to (166)Ho-microspheres radioembolization in patients with liver metastases
por: Smits, Maarten L. J., et al.
Publicado: (2019)

Lung Perfusion Imaging with Technetium-99m Macroaggregated Albumin should be Combined with Contrast-enhanced Echocardiography for the Diagnosis of Hepatopulmonary Syndrome
por: Meristoudis, Georgios, et al.
Publicado: (2020)

Clinical and Laboratory Toxicity after Intra-Arterial Radioembolization with (90)Y-Microspheres for Unresectable Liver Metastases
por: Smits, Maarten L. J., et al.
Publicado: (2013)

Assessment of Technetium-99m Labeled Macroaggregated Albumin Rhinoscintigraphy for the Measurement of Nasal Mucociliary Transport Rate: Intratest, Interobserver, and Intraobserver Reproducibility
por: Dostbil, Zeki, et al.
Publicado: (2014)

Correction: Clinical and Laboratory Toxicity after Intra-Arterial Radioembolization with (90)Y-Microspheres for Unresectable Liver Metastases
por: Smits, Maarten L. J., et al.
Publicado: (2013)

(166)Holmium–(99)(m)Technetium dual-isotope imaging: scatter compensation and automatic healthy-liver segmentation for (166)Holmium radioembolization dosimetry
por: Stella, Martina, et al.
Publicado: (2022)

Reply to Comment on: Lung Perfusion Imaging with Technetium-99m-macroaggregated Albumin should be Combined with Contrast-enhanced Echocardiography for the Diagnosis of Hepatopulmonary Syndrome
por: Assadi, Majid
Publicado: (2021)

Relationship of (99m)technetium labelled macroaggregated albumin ((99m)Tc-MAA) uptake by colorectal liver metastases to response following Selective Internal Radiation Therapy (SIRT)
por: Dhabuwala, Atul, et al.
Publicado: (2005)

Yttrium-90 Radioembolization: An Unusual Cause of Radiating Abdominal Pain
por: Estes, Derek J., et al.
Publicado: (2019)

Side Effects of Yttrium-90 Radioembolization
por: Riaz, Ahsun, et al.
Publicado: (2014)

Holmium-166 radioembolization for the treatment of patients with liver metastases: design of the phase I HEPAR trial
por: Smits, Maarten LJ, et al.
Publicado: (2010)

History and Evolution of Yttrium-90 Radioembolization for Hepatocellular Carcinoma
por: Saini, Aman, et al.
Publicado: (2019)

Verification Study of Residual Activity Measurements After Yttrium-90 Radioembolization with Glass Microspheres
por: Ebbers, S. C., et al.
Publicado: (2020)

Review of diagnostic uses of shunt fraction quantification with technetium-99m macroaggregated albumin perfusion scan as illustrated by a case of Osler–Weber–Rendu syndrome
por: Chokkappan, Kabilan, et al.
Publicado: (2016)

Celiac Artery Stenting to Facilitate Hepatic Yttrium-90 Radioembolization Therapy
por: Chamarthy, Murthy R., et al.
Publicado: (2012)

Non-invasive monitoring of photodynamic therapy with 99technetium HMPAO scintigraphy.
por: Moore, R. B., et al.
Publicado: (1992)

Correlation of C-arm CT acquired parenchymal blood volume (PBV) with (99m)Tc-macroaggregated albumin (MAA) SPECT/CT for radioembolization work-up
por: Weissinger, Matthias, et al.
Publicado: (2020)

Voxel-S-Value based 3D treatment planning methods for Y-90 microspheres radioembolization based on Tc-99m-macroaggregated albumin SPECT/CT
por: Chen, Gefei, et al.
Publicado: (2023)

Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma
por: Kallini, Joseph Ralph, et al.
Publicado: (2016)

Radioguided localisation of impalpable breast lesions using 99m-Technetium macroaggregated albumin: Lessons learnt during introduction of a new technique to guide preoperative localisation
por: Landman, Joanne, et al.
Publicado: (2015)

Technetium-99m-labeled macroaggregated albumin lung perfusion scan for diagnosis of hepatopulmonary syndrome: A prospective study comparing brain uptake and whole-body uptake
por: Zhao, He, et al.
Publicado: (2020)

Use of C-Arm Cone Beam CT During Hepatic Radioembolization: Protocol Optimization for Extrahepatic Shunting and Parenchymal Enhancement
por: van den Hoven, Andor F., et al.
Publicado: (2015)

Assessment of Treatment Response Following Yttrium-90 Transarterial Radioembolization of Liver Malignancies
por: Adcock, Charles S, et al.
Publicado: (2018)

Non Target Shunting of Tc-99m Macroaggregates of Albumin and Radiolabeled Yttrium-90 Microspheres into Hepatic Falciform Artery - Less Observed Arterial Variant not to be Overlooked
por: Sundaraiya, Sumati, et al.
Publicado: (2023)

Intrahepatic flow diversion prior to segmental Yttrium-90 radioembolization for challenging tumor vasculature
por: Young, Lindsay B., et al.
Publicado: (2022)

Yttrium-90 radioembolization for advanced inoperable hepatocellular carcinoma
por: Lee, Victor Ho-Fun, et al.
Publicado: (2015)

Internal dosimetry for radioembolization therapy with Yttrium‐90 microspheres
por: Fallahpoor, Maryam, et al.
Publicado: (2017)

Role of Yttrium-90 Radioembolization for Colorectal Hepatic Metastasis
por: Kim, Hyo-Cheol
Publicado: (2022)

Yttrium-90 Radioembolization as the Major Treatment of Hepatocellular Carcinoma
por: Yu, Chun-Yen, et al.
Publicado: (2023)

Mapping angiography and transarterial technetium macroaggregated albumin particle simulation of recurrent atypical intracranial meningioma: feasibility for potential vascular brachytherapy
por: Toskich, Beau B., et al.
Publicado: (2020)

Poor renal uptake of technetium-99m-DMSA and technetium-99m-MDP in a patient with Fanconi syndrome and near normal glomerular filtration rate.
por: Kim, S. E., et al.
Publicado: (1994)

Standardizing SPECT/CT dosimetry following radioembolization with yttrium-90 microspheres
por: Kim, S. Peter, et al.
Publicado: (2021)

Options for UK Technetium-99m Production using Accelerators
por: H.L. Owen, et al.
Publicado: (2014)

(99m)Technetium Sestamibi-(123)Iodine Scintigraphy Is More Accurate Than (99m)Technetium Sestamibi Alone before Surgery for Primary Hyperparathyroidism
por: Ryhänen, Eeva M., et al.
Publicado: (2015)

Predictors of Successful Yttrium-90 Radioembolization Bridging or Downstaging in Patients with Hepatocellular Carcinoma
por: Villalobos, Alexander, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7s9huienc91lovp17odfoundgc